Journal of Nanobiotechnology, 2022 · DOI: https://doi.org/10.1186/s12951-022-01495-6 · Published: June 4, 2022
Traumatic brain injury (TBI) can cause disability and death, and currently lacks specific treatments. The release of excess reactive oxygen species (ROS) after injury leads to further pathological changes. The study explores eliminating ROS as a potential therapy. The researchers synthesized insulin-incubated palladium (Pd@insulin) clusters, approximately 3.2 nm in diameter, using a green biomimetic chemistry approach. These clusters demonstrated marked multiple ROS-scavenging ability and were rapidly excreted with negligible adverse effects. In a TBI mouse model, intravenous injection of Pd@insulin clusters effectively suppressed excessive ROS production in the injured cortex. This significantly rescued motor function, cognition, and spatial memory, mainly due to their ROS-scavenging ability which inhibited neuroinflammation and reduced neuronal loss.
The simple structure, easy synthesis, low toxicity, and rapid metabolism of Pd@insulin clusters may facilitate their clinical translation for TBI treatment.
The biomimetic and scalable process used to synthesize Pd@insulin could inspire the development of other nanodrugs for treating TBI or other ROS-related diseases.
Using insulin to facilitate BBB penetration of nanoparticles may lead to more effective targeted nanodrug delivery strategies for brain injuries and disorders.